Migraine and dementia sufferers were just two patient-groups to see new products launched for generic prescription, by Teva UK Limited in early 2012. We’ve launched 20 medicines this year so far, find out more...
Kim Innes, Commercial Director at Teva UK Limited said: “We will continue to support the NHS, patients and pharmacists so that they continue to benefit from a strong supply and choice from a wide product portfolio and competitive prices from products launched after patent expiries.”
One in six prescriptions
Teva UK Limited is the leader in generic medicines in the UK, with a growing presence in branded areas such as respiratory and in the hospital sector.
More than one in six dispensed prescription packs is a Teva product and it has strong product development pipeline, wide-range of products and award-winning packaging.
Supporting the NHS in saving £9bn
Kim continued: “We want to make more medicines accessible for more people, so I’m particularly pleased that we’re able to keep adding further medicines to our wide-ranging portfolio, from day one. It means that we continue to do our bit in saving the NHS over £9bn a year.”